PI3KCA, AKT1, PTEN, TSC1/2, or LKB1 modifications and PI3KCA alterations are frequently described in breast (> 20%), colon, and gynecologic cancers. PTEN mutations occur in colorectal cancers and about 10% of central nervous system malignancies. Here, PTEN is linked to colorectal cancer.